Improving gut health with human milk oligosaccharides17 May 2019
2’-FL a very promising agent for digestive health across various age groups beyond infancy.
BASF and Glycosyn have signed a partnership agreement for the development and commercialization of human milk oligosaccharides (HMOs) for broad use in dietary supplements, functional nutrition, and medical food. The strategic partnership includes exclusive license of Glycosyn's patent portfolio for gut health beyond infant nutrition to BASF. The agreement aims to improve gastrointestinal health in adolescents and adults, along with broadening the applications of HMO for further health conditions.
As part of the collaboration and under the exclusive license, BASF will extend its offering of the most abundant HMO, 2’-Fucosyllactose (2’-FL) branded Prebilac, to a broad range of customers worldwide. Glycosyn will leverage its scientific expertise and extensive collaboration with the HMO research community to expand the evidence for adult health.
Emerging scientific evidence shows that 2’-FL supports the development and maintenance of a healthy gut microbiome and immune system. Based on its prebiotic functions and the ability to inhibit pathogen adhesion and modulate immune functions, 2’-FL is a very promising agent for digestive health across various age groups beyond infancy.
“Extending the reach of nature-designed HMO molecules from infant nutrition to dietary supplements, functional nutrition, and medical food addresses unmet consumer health needs and unlocks a huge market potential. Partnering with Glycosyn, the pioneer in the field of HMOs, to establish synergies and advance the science on HMOs for human gut health and even beyond, creates significant value for us and profound benefits for consumers,” said Tina Low, Vice President, Business Management Human Nutrition at BASF.
“The time has come to bring the benefits of HMO to consumers worldwide who suffer from gut discomfort or even diseases such as irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD). BASF’s scaled state-of-the-art production and extensive global customer access makes them the ideal partner for us to jointly tap into this huge market potential and take nutrition to the next level,” added John Garrett, co-CEO, Glycosyn.
New HCP Kit for automated impurity analysis of biotherapeutics
21 Jun 2019
Ready-to-use immunoassay kit increases analytical output and productivity in bioprocess workflows.Read more
Sanofi and Google to develop new healthcare Innovation Lab
20 Jun 2019
Collaboration aims to change how Sanofi develops new treatments and will focus on to better understand patients and diseases, to increase Sanofi’s operational efficiency, and to improve the experience of Sanofi’s patients and customers.Read more
Catalent to purchase BMS manufacturing facility
19 Jun 2019
Customers to have access to state-of-the-art sterile biologics fill/finish and oral solids manufacturing and packaging platforms.Read more
Inaugural Bio Integrates conference highlights industry's inefficiency in developing products
18 Jun 2019
Industry leaders give voice to issues and trends shaping the biotech sector, including the importance of collaboration.Read more
Colorcon launches Opadry Enteric for use with hydro-alcoholic media
17 Jun 2019
A fully formulated one-step system providing simple preparation and ease-of-use for film coating.Read more
SenzaGen granted its first patent for GARD potency biomarker test
16 Jun 2019
Company can now offer an animal-free test method to quantify the strength of an allergenic effect.Read more
Affordable measles and rubella vaccines using NevoLine manufacturing platform
14 Jun 2019
Univercells' propriety bioproduction platform has already proven success.Read more
Leaf Expression Systems launches first line of Hypertrans research products
13 Jun 2019
Plant-expression deal for difficult to produce proteins, vaccines, metabolites and natural proteins.Read more
Clinical supply milestone reached for triple-negative breast cancer treatment
12 Jun 2019
PhoenixMD and WuXi STA have produced a multikilogram drug supply for PMD-026 under GMP manufacturing practices.Read more
Combining IT and OT software to solve manufacturing’s most frequent challenges
11 Jun 2019
PTC and Rockwell Automation combine technologies to accelerate customers’ digital transformation initiatives.Read more
Are you a supplier
Here's what we can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation